Clinical Trial

A Clinical Trial to Evaluate the Relative Bioavailability of PRAX-628

Completed Phase 1
View on ClinicalTrials.gov →
Summary
A phase I clinical trial to evaluate the relative bioavailability of PRAX-628 tablet formulation compared to capsule formulation
Protocol Amendment History 1 change
critical Completed without a posted recruiting period 2026-08-04
Trial Details
NCT Number NCT06840925
Lead Sponsor Praxis Precision Medicines
Conditions Healthy
Enrollment 16 participants
Start Date 2025-04-28
Primary Completion 2025-06-05 (estimated)
Study Completion 2025-06-05 (estimated)
Updated on ClinicalTrials.gov 2026-08-03